The Future of Hematology – XN- Series Technology 16 PLT-F Channel PLT performance • Impedance...
Transcript of The Future of Hematology – XN- Series Technology 16 PLT-F Channel PLT performance • Impedance...
1/28/2013
1
Copyright© Sysmex America, Inc. – Confidential, Not for Distribution
The Future of Hematology – XN-Series Technology
Pending FDA Clearance. For Investigational Use OnlyNot Available for Sale in the United States
Performance Characteristics have not been Established.
Objectives
• Describe the advantages of the new technologies available on the XN-Series
• Utilize case studies to demonstrate how fluorescent flow cytometry technology used on the XN can improve efficiency and productivity.
• Understand and be able to explain the advantages of utilizing non-traditional Hematology parameters to aid the clinician in the diagnosis and treatment of anemia and thrombocytopenia)
1/28/2013
2
XN-Series
It all begins here….
XN-Series:Addresses Needs Of All Segments
Single Analytical Module
Multiple Options
1/28/2013
3
Copyright© Sysmex America, Inc. – Confidential, Not for Distribution
Compact Automation Solutions
XN-2000
XN-1000
XN-3000
Copyright© Sysmex America, Inc. – Confidential, Not for Distribution
Scalable Automation Solutions
XN-9000
1/28/2013
4
XN-Series Technology
Sysmex XE vs. XN Technology
RBC, PLT, Hgb
WNR WDF RET PLT-F
NEW NEW NEW
1/28/2013
5
Fluorescent Flow Cytometry
Side Fluorescent LightDNA/RNA information
Side Scattered LightCell inside structure information
Forward Scattered LightCell size information
Dichroic Mirror
Laser Beam wavelength=633nm
WNR Channel
1/28/2013
6
WNR ChannelReagent Reaction
BASO LYMPH MONO Granulocyte
NRBC RBC
WNR Channel Scattergram - Normal Pattern
NRBC
WBC
BASO
Debris SFL
FS
C
1/28/2013
7
NRBC - XE-5000
NRBC - XN WNR
1/28/2013
8
Acute Erythroid Leukemia (AML-M6)
Acute Erythroid Leukemia (AML-M6)
1/28/2013
9
FS
C
SFLSFL
Advantage of Fluorocell WNR
WNR Channel
• Fluorescent Flow Cytometry Technology
• Maximized Efficiency
• NRBC the first time – all the time
– No additional steps
– Accurate WBC Counts in the presence of NRBCs
– No additional reagent needed
• Virtually eliminates interference from:
• Lyse resistant RBCs
• Lipids
1/28/2013
10
WDF Channel
WDF Channel Reagent Reaction
LYMPH MONO NEUT EO
Atypical LYMPH Immature WBC
1/28/2013
11
WDF Channel Scattergram - Normal Pattern
LYMPH NEUT+BASO
EO
MONO
Debris
IG
Immature Granulocytes
1/28/2013
12
IG – XN DIFF Abstract
So what’s different about the WDF?
XN flagging system improves work flow by reducing manual reviews
Enhanced Flagging
1/28/2013
13
Enhanced Flagging Algorithms
(Sysmex Adaptive Flagging Algorithm based on Shape-recognition)
LDA (Linear Discriminant Analysis)
Detects abnormal cells - (with high sensitivity)
SAFLAS method
Normal Abnormal (Blasts?) Abnormal (Abn Lympho?)
WDF SAFLAS Method
1/28/2013
14
WDF Channel
• Enhanced Flagging
• Better separation between lymphs and monos (SAFLAS)
• Better identification of platelet clumps (multiple channel detection)
• Auto-correction of lymphs when NRBCs are present
• 6-part differential (including IG)
Copyright © 2012 by Sysmex America, Inc. All rights reserved.
Low WBC Analysis Mode
WB (Whole Blood) mode LW (Low WBC) mode
Dilution Rate :Analysis Volume :Whole Counts *2 :
Dilution Rate :Analysis Volume :Whole Counts *2 :
x 61.158.2µL9,530
x 61.1174.6µL28,600
Analysis Time extended to 3 times the Whole Blood WBC count time
1/28/2013
15
Low WBC Analysis Mode
• Analysis time extended to 3 times WB WBC count time
• Better accuracy and precision on counts < 0.50 x 103
• No Vote Outs – Differential results on all counts
• Increased reportable differentials
PLT-F Channel
1/28/2013
16
PLT-F Channel
PLT performance• Impedance platelet analysis (size) has limitations in the identification
and discrimination of platelets from interfering particles with the same size.
• Possible interferences
– RBC fragments counted as platelets: falsely high
– Microcytic RBCs counted as platelets: falsely high
– Large platelets counted as RBC: falsely low
PLT-F Channel
Reagent Reaction
RBC PLT IPF
1/28/2013
17
PLT-F Channel
Reportable Parameters
PLT-FIPF
.
Fluorocell PLT Staining
PLT WBCRBC
Flu
oroc
ell P
LTR
ET
SE
AR
CH
II
Low RBC background
(because of using only one staining dye, oxazine) WBCs were stained by both dyes.
Dye binds diffusely spread throughout.
Dye binds some structures more strongly.
High RBC background WBCs were stained by both dyes.
1/28/2013
18
Binding sites of Fluorocell PLT
open tubuleα granule
←glycogen granule
microtubule
deep dyeing granule
rough-surfaced endoplasmic reticulum
Fluorocell PLT stains nucleic acid rich organelle
• Rough-surfaced endoplasmic reticulum (ribosomal RNA)
• Mitochondria (MtDNA)
mitochondria
RBCRBC
PLT-F separates platelets from RBC fragment by the differences in staining
• CD41/CD61 positive = Platelets
• Staining by PLT-F dedicated reagent
– Platelets - Strong, especially within the cell
– RBC fragments - Weak, only cell membrane
RBC Fragment
Platelet
Transmitted light
CD61/PLT-F
Transmitted light
1/28/2013
19
Interference with Routine Impedance Count
ß-Thalassemia Major with numerous fragmented red cells
XN: PLT-FXE: PLT-O
PLT-I
XE: PLT-I
XEPLT-I = 477*109/L PLT-0 = 111*109/LPLT-CD61 =152.2*109/LIPF% = 13.9%
XNPLT-I = 514*109/L PLT-F = 140.8*109/LPLT-CD61 = 152.2*109/LIPF%= 12.9%
Microcytic RBC
Microcytic RBCMicrocyticRBC
Improved Performance of PLT-FAcute Prolymphocytic Leukemia / chemo: white blood cell fragments
XNPLT-I = 28*109/L PLT-F = 24.2*109/LPLT-CD61 = 24.2*109/L IPF% = 1.1%IPF# = 0.3*109/L
XEPLT-I = 25*109/L PLT-0 = 181*109/LPLT-CD61 = 24.2*109/LIPF% = 41.2%IPF# = 74.6*109/L
XN: PLT-FXE: PLT- O
WBC cytoplasm fragments
IPF
PLT-F
WBC cytoplasm fragments
1/28/2013
20
PLT-F ChannelScattergram - Normal Pattern
RBC
PLT-F
IPF
PLT-F Channel
• Second method of platelet
• Fluorescent Dye specific for platelet organelle
• Extended count time (6 times) for accurate platelet enumeration, especially in low platelet counts
• Good comparison with CD41/CD61
• Minimizes interference from RBC fragments, microcytic RBC’s and WBC fragments
• Automated Action message and reflex with on board rules
1/28/2013
21
Reticulocyte Channel
RET Channel
Reagent Reaction
RET RBCWBC PLT
1/28/2013
22
RET Channel Scattergram on Normal Pattern
PLT
RET
HFRRBC
MFRLFR
IRF
Reticulocyte Parameters
• Reticulocytes – # and % of immature RBC’s
• Immature Reticulocyte Fraction– Newly released from the
marrow, a direct cellular measurement of erythropoiesis
• Reticulocyte Hemoglobin– Direct cellular measure of iron
availability
1/28/2013
23
Reticulocyte Hemoglobin(Ret-He/CHr)
• Measured at cellular level
• Monitor acute changes in hemoglobin incorporation into the erythron
• Real-time estimate of iron availability in bone marrow
• Shown as a more sensitive tool for early detection of iron deficiency
• Changes rapidly, more sensitive screen than Hb
• Less variation than acute phase reactants
• Provides additional information for managing iron requirements for ESA therapy
• Limitation in specificity addressed by interpreting Ret-He results in conjunction with other tests and clinical picture
K-DOQI Guidelines Evaluation of Anemia
Initial anemia evaluation– Cellular Assessment
CBC• Hgb < 12 g/dL
• RBC indices
• Absolute Retic
• WBC & Diff
• Platelet
– Iron Assessment• Serum ferritin
• Serum TSAT or Hb content of reticulocytes
Iron Assessment– HD-CKD Target
• Hemoglobin > 11 g/dl
• Tsat > 20%
• Ferritin > 200 ng/ml or Reticulocyte Hgb > 29 pg/cell
NKF/K-DOQI May 2006
Analysis of Iron Status in Clinical Laboratories, M. Schaefer et al, SJI Vol 11 No 2 (2001)
1/28/2013
24
Reticulocyte Channel
• Operational Efficiency– Reduced Interference From:
• WBCs
• Howell Jolley Bodies
• Parasites
• Sickle cells
– Quick and automatic
• Monitor RBC development at the cellular level – IRF for Retic production
– RET-He for iron incorporation in hemoglobin of the erythron
• Clinically relevant information for the management of anemia in conjunction with other available clinical information.
1/28/2013
25
Body Fluid Analysis
Body Fluid Analysis
Cerebrospinal fluid (CSF)
Body fluid mode (target species)
Pleural fluid
Peritoneal fluid
Synovial fluid
HF-BF
MN
PMN
MO-BF
LY-BF
EO-BFNE-BF
WDF Scattergram
1/28/2013
26
Body Fluid Analysis
• No pre-analysis preparation
• No additional reagents
• Automated background counts
• Rapid analysis
XN Technology Summary
• WNR Channel– Maximized efficiency
– NRBC the first time – all the time
– Accurate WBC Counts in the presence of NRBCs
• WDF, Low WBC– Enhanced Flagging
– 6-part differential (including IG)
– Improved Sensitivity and Specificity
1/28/2013
27
XN Technology Summary
• Low WBC– Better accuracy and precision on counts < 0.50 x 103
– No Vote Outs – Differential results on all counts
– Increased Reportable differentials
• PLT-F– Fluorescent Dye specific for platelet organelle
– Extended count time (6 times) for accurate low platelet enumeration
– Good comparison with CD41/CD61
– Automated Action message and reflex with on board rules
XN Technology
Hematology Technology of the Future Today